561 related articles for article (PubMed ID: 27521363)
1. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
2. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis.
Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH
PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809
[TBL] [Abstract][Full Text] [Related]
3. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
4. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
5. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
6. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
[TBL] [Abstract][Full Text] [Related]
7. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
[TBL] [Abstract][Full Text] [Related]
8. Bacterial colonization and beta defensins in the female genital tract in HIV infection.
Jiang W; Ghosh SK; Flyckt R; Kalinowska M; Starks D; Jurevic R; Weinberg A; Lederman MM; Rodriguez B
Curr HIV Res; 2012 Sep; 10(6):504-12. PubMed ID: 22716110
[TBL] [Abstract][Full Text] [Related]
9. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
[TBL] [Abstract][Full Text] [Related]
10. Vaginal flora in HPV infection: a cross‑sectional analysis.
Dou P; Fang F; Qin R; Nie J; Chen X; Yin X; Wang Y; Shi S
J Obstet Gynaecol; 2024 Dec; 44(1):2361847. PubMed ID: 38861397
[TBL] [Abstract][Full Text] [Related]
11. Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark.
Wessman M; Thorsteinsson K; Jensen JS; Storgaard M; Rönsholt FF; Johansen IS; Pedersen G; Nørregård Nielsen L; Bonde J; Katzenstein TL; Weis N; Lebech AM
BMC Infect Dis; 2017 May; 17(1):376. PubMed ID: 28569142
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
[TBL] [Abstract][Full Text] [Related]
13. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
14. Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
Onywera H; Anejo-Okopi J; Mwapagha LM; Okendo J; Williamson AL
PLoS One; 2021; 16(6):e0253218. PubMed ID: 34143825
[TBL] [Abstract][Full Text] [Related]
15. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
16. Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.
Mitchell C; Balkus JE; Fredricks D; Liu C; McKernan-Mullin J; Frenkel LM; Mwachari C; Luque A; Cohn SE; Cohen CR; Coombs R; Hitti J
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):13-9. PubMed ID: 23020644
[TBL] [Abstract][Full Text] [Related]
17. Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types.
Huang X; Li C; Li F; Zhao J; Wan X; Wang K
Int J Cancer; 2018 Aug; 143(3):621-634. PubMed ID: 29479697
[TBL] [Abstract][Full Text] [Related]
18. Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
Buckley N; Huber A; Lo Y; Castle PE; Kemal K; Burk RD; Strickler HD; Einstein MH; Young M; Anastos K; Herold BC
Am J Reprod Immunol; 2016 Feb; 75(2):146-54. PubMed ID: 26685115
[TBL] [Abstract][Full Text] [Related]
19. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis.
Borgogna JC; Shardell MD; Santori EK; Nelson TM; Rath JM; Glover ED; Ravel J; Gravitt PE; Yeoman CJ; Brotman RM
BJOG; 2020 Jan; 127(2):182-192. PubMed ID: 31749298
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.
Di Paola M; Sani C; Clemente AM; Iossa A; Perissi E; Castronovo G; Tanturli M; Rivero D; Cozzolino F; Cavalieri D; Carozzi F; De Filippo C; Torcia MG
Sci Rep; 2017 Aug; 7(1):10200. PubMed ID: 28860468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
